MedTrace Logo

Effect of Lutein in S-26 Gold On Growth And Safety

NCT00913406 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 232

Last updated 2009-06-04

No results posted yet for this study

Summary

Study to determine if the addition of lutein to infant formula supports healthy growth and development in healthy full term infants.

Conditions

  • Healthy

Interventions

OTHER

Lutein fortification

OTHER

Standard formula

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-11-30
Primary Completion
2006-05-31
Completion
2006-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00913406 on ClinicalTrials.gov